ETVAX® vaccine
ETEC, ®
ETVAX® is a tetravalent ETEC vaccine containing four formaldehyde- or phenol-inactivated recombinant Each vaccine vial contains ~8.0 × 10The vaccine vials were produced and released by Cobra Biologics, Matfors, Sweden. The oral dmLT adjuvant LT(R192G/L211A), a genetically modified derivative of wild-type ETEC LT, was produced as a separate lyophilized vial (IDT Biologika GmbH, Germany); the final amount of dmLT was 10 μg/dose.